In a recent publication involving SWEHSC members Drs. Scott Boitano and Julie Ledford, researchers tested a compound, C781, to see how effective it is as a targeted approach that addresses allergen-induced symptoms in an animal model. C781 was developed through testing on human cells from the air passages that lead to and through the lungs (bronchial tubes) before being tested in mice for allergen-induced asthma. These tests indicate C781 is an effective treatment for allergen-induced asthma-like symptoms in the airway.
